Rahul Atul Parikh

1.3k total citations
69 papers, 816 citations indexed

About

Rahul Atul Parikh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Rahul Atul Parikh has authored 69 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 17 papers in Surgery. Recurrent topics in Rahul Atul Parikh's work include Prostate Cancer Treatment and Research (18 papers), Renal cell carcinoma treatment (13 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Rahul Atul Parikh is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Renal cell carcinoma treatment (13 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Rahul Atul Parikh collaborates with scholars based in United States and Japan. Rahul Atul Parikh's co-authors include Leonard J. Appleman, Ali Imran Amjad, Susanne M. Gollin, Kathan Mehta, Shivendra V. Singh, William S. Saunders, Edward Chu, Eun‐Ryeong Hahm, Jan H. Beumer and Peng Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Rahul Atul Parikh

62 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rahul Atul Parikh United States	17	385	333	251	188	149	69	816
Patrick J. Hensley United States	15	336 0.9×	216 0.6×	249 1.0×	313 1.7×	132 0.9×	75	848
Ofer Margalit Israel	15	330 0.9×	382 1.1×	127 0.5×	96 0.5×	209 1.4×	52	824
Hakim Mahammedi France	14	204 0.5×	470 1.4×	426 1.7×	118 0.6×	111 0.7×	55	869
Ying Tian China	16	347 0.9×	236 0.7×	112 0.4×	100 0.5×	177 1.2×	40	686
Runsen Jin China	19	520 1.4×	410 1.2×	456 1.8×	150 0.8×	259 1.7×	54	1.1k
Margherita Ratti Italy	14	385 1.0×	397 1.2×	283 1.1×	167 0.9×	359 2.4×	48	1.0k
Patrick Dorn Switzerland	16	267 0.7×	228 0.7×	510 2.0×	169 0.9×	121 0.8×	75	952
Xiuyi Zhi China	17	355 0.9×	327 1.0×	355 1.4×	71 0.4×	164 1.1×	66	874
Sakkaraiappan Ramalingam United States	12	376 1.0×	334 1.0×	334 1.3×	125 0.7×	90 0.6×	30	909

Countries citing papers authored by Rahul Atul Parikh

Since Specialization

Citations

This map shows the geographic impact of Rahul Atul Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Atul Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Atul Parikh more than expected).

Fields of papers citing papers by Rahul Atul Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Atul Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Atul Parikh. The network helps show where Rahul Atul Parikh may publish in the future.

Co-authorship network of co-authors of Rahul Atul Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Atul Parikh. A scholar is included among the top collaborators of Rahul Atul Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Atul Parikh. Rahul Atul Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kyriakopoulos, Christos E., Yu‐Hui Chen, Robert Jeraj, et al.. (2024). Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153).. Journal of Clinical Oncology. 42(17_suppl). LBA5000–LBA5000. 2 indexed citations

Wulff‐Burchfield, Elizabeth, Saqib Abbasi, J. Donald, et al.. (2024). PSA flare in patients with metastatic castration-resistant prostate cancer undergoing ¹⁷⁷Lu-PSMA treatment.. Journal of Clinical Oncology. 42(4_suppl). 157–157.

Pan, Elizabeth, Wanling Xie, Archana Ajmera, et al.. (2023). A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Molecular Cancer Therapeutics. 22(4). 511–518. 29 indexed citations

Jani, Chinmay, Wanling Xie, Archana Ajmera, et al.. (2023). A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress.. Journal of Clinical Oncology. 41(16_suppl). TPS5110–TPS5110.

Sadeghi, Sarmad, Rahul Atul Parikh, Denice Tsao‐Wei, et al.. (2022). Phase II randomized double blind trial of axitinib (Axi) +/- PF-04518600, an OX40 antibody (PFOX) after PD1/PDL1 antibody (IO) therapy (Tx) in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 40(16_suppl). 4529–4529. 9 indexed citations

Malleshappa, Sudeep K Siddappa, Smith Giri, Smit Patel, et al.. (2021). Overall survival based on oncologist density in the United States: A retrospective cohort study. PLoS ONE. 16(5). e0250894–e0250894. 5 indexed citations

Malleshappa, Sudeep K Siddappa, Tapan Mehta, Smit Patel, et al.. (2020). Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope. PLoS ONE. 15(4). e0230859–e0230859. 2 indexed citations

Mehta, Kathan, Sudeep K Siddappa Malleshappa, Smit Patel, et al.. (2019). Trends of Inpatient Venous Thromboembolism in United States Before and After the Surgeon General's Call to Action. The American Journal of Cardiology. 124(6). 960–965. 9 indexed citations

Voss, Martin H., Rupal S. Bhatt, Nicholas J. Vogelzang, et al.. (2019). A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. Cancer. 125(14). 2400–2408. 21 indexed citations

10.

Appleman, Leonard J., Theodore F. Logan, Daniel P. Normolle, et al.. (2018). Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study.. Journal of Clinical Oncology. 36(5_suppl). 106–106. 3 indexed citations

11.

Ali, Siraj M., et al.. (2018). A prolonged response to platinum‐based therapy in a patient with metastatic urothelial carcinoma harboring a single rearranged and truncated NF2 gene. Genes Chromosomes and Cancer. 57(8). 430–433. 2 indexed citations

12.

Roy, Somak, Dinesh Pradhan, Yana G. Najjar, et al.. (2017). Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma. Modern Pathology. 30(8). 1133–1143. 45 indexed citations

13.

Shore, Neal D., Elisabeth I. Heath, Luke T. Nordquist, et al.. (2017). Safety and immunogenicity of a DNA-vaccine immunotherapy in men with biochemically (PSA) relapsed prostate cancer. Annals of Oncology. 28. v272–v272. 1 indexed citations

14.

Mehta, Kathan, Keyur Patel, & Rahul Atul Parikh. (2017). Immunotherapy in genitourinary malignancies. Journal of Hematology & Oncology. 10(1). 95–95. 30 indexed citations

15.

Parikh, Rahul Atul, Leonard J. Appleman, Jan H. Beumer, Ewa Matczak, & Edward Chu. (2016). Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features. Clinical Genitourinary Cancer. 15(1). 7–22. 1 indexed citations

16.

Sakao, Kozue, Avani R. Vyas, Sreenivasa R. Chinni, et al.. (2015). CXCR4 Is a Novel Target of Cancer Chemopreventative Isothiocyanates in Prostate Cancer Cells. Cancer Prevention Research. 8(5). 365–374. 16 indexed citations

17.

Amjad, Ali Imran, et al.. (2015). Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside. Current Pharmacology Reports. 1(6). 382–390. 52 indexed citations

18.

Appleman, Leonard J., Rahul Atul Parikh, Peng Wang, Jan H. Beumer, & Edward Chu. (2014). The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment. OncoTargets and Therapy. 7. 969–969. 59 indexed citations

19.

Amjad, Ali Imran & Rahul Atul Parikh. (2013). Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome. Blood. 122(20). 3403–3403. 12 indexed citations

20.

Parikh, Rahul Atul, Jason S. White, Xin Huang, et al.. (2007). Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes and Cancer. 46(8). 761–775. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact